Downregulation of Bcl-x L and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy

Apoptosis Supercedes Necrosis in Mitochondrial DNA-Depleted Jurkat Cells by Cleavage of Receptor-Interacting Protein and Inhibition of Lysosomal Cathepsin

(2014) T. Sato et al.   JOURNAL OF IMMUNOLOGY

Small silencing RNAs: State-of-the-art

(2009) Dirk Grimm   ADVANCED DRUG DELIVERY REVIEWS

Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cells

(2009) Lin Jie Zhang et al.   ANTI-CANCER DRUGS

Concepts in in vivo siRNA delivery for cancer therapy

(2009) Christopher S. Gondi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Malignant Pleural Mesothelioma

(2009) Anne S. Tsao et al.   JOURNAL OF CLINICAL ONCOLOGY

Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737

(2009) P. Hauck et al.   MOLECULAR CANCER THERAPEUTICS

Malignant Mesothelioma Resistance to Apoptosis: Recent Discoveries and their Implication for Effective Therapeutic Strategies

(2008) M. Rippo et al.   CURRENT MEDICINAL CHEMISTRY

Resistance mechanisms to cancer chemotherapy

(2008) Kelly Marie Redmond   Frontiers in Bioscience-Landmark

Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts

(2008) James E. Littlejohn et al.   INTERNATIONAL JOURNAL OF CANCER

Recent Advances in the Treatment of Malignant Pleural Mesothelioma

(2008) Suresh S. Ramalingam et al.   Journal of Thoracic Oncology

Bcl-2 family proteins and cancer

(2008) K W Yip et al.   ONCOGENE

Small-Molecule Inhibitors of Bcl-2 Family Proteins as Therapeutic Agents in Cancer

(2008) Ramzi Mohammad et al.   Recent Patents on Anti-Cancer Drug Discovery

The BCL-2 protein family: opposing activities that mediate cell death

(2007) Richard J. Youle et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY